Who is the CEO of NKTX? | Glauxie AI

Q: Who is the CEO of NKTX?

Nkarta, Inc. (NKTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Paul J. Hastings. Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric... Employees: 200,000.

Q: What does NKTX company do?

Learn what NKTX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling NKTX?

Track recent insider buys and sells for NKTX with transaction details, amounts, and trends.

Q: What sector is NKTX in?

Find NKTX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of NKTX?

🦉

Nkarta, Inc. (NKTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOPaul J. Hastings

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific...

Key Executives

Name	Title
Nadir Mahmood	President and Principal Accounting & Financial Officer
Paul J. Hastings	Chief Executive Officer & Director
Shawn Rose	Chief Medical Officer and Head of Research & Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

NKTX Profile Financials

What does NKTX company do? Are insiders buying or selling NKTX? What sector is NKTX in?